p21Waf1/Cip1 as a molecular sensor for BoHV-4 replication

被引:3
|
作者
Capocefalo, A. [1 ]
Franceschi, V. [1 ]
Whitelaw, C. B. A. [2 ,3 ]
Vasey, D. B. [2 ,3 ]
Lillico, S. G. [2 ,3 ]
Cavirani, S. [1 ]
Donofrio, G. [1 ]
机构
[1] Fac Med Vet, Dipartimento Salute Anim, Sez Malattie Infett Anim, I-43100 Parma, Italy
[2] Univ Edinburgh, Div Dev Biol, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland
[3] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland
基金
英国生物技术与生命科学研究理事会;
关键词
BoHV-4; p21(Waf1/Cip1); Cellular damage; CYCLIN-DEPENDENT KINASES; BOVINE HERPESVIRUS-4; DNA-DAMAGE; P21; IDENTIFICATION; INHIBITION; VIRUS; P53;
D O I
10.1016/j.jviromet.2009.06.012
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
BoHV-4 replication cycle is dependent on the S-phase of the cell-cycle at the stage of viral DNA synthesis. Because p21 is a rate-limiting regulator of the G1/S-phase transition and up-regulated by DNA-damaging agents, in this study p21 expression in BoHV-4 infected cells was investigated. The p21 promoter was found to be highly activated in a dose- and time-dependent manner following BoHV-4 infection only in cells which are permissive for BoHV-4 replication. Thus p21 expression reports on BoHV-4 replication and could represent a host cell defensive response to infection-associated cellular damage. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:308 / 311
页数:4
相关论文
共 50 条
  • [1] p21WAF1/CIP1 and cancer: A shifting paradigm?
    Gartel, Andrei L.
    BIOFACTORS, 2009, 35 (02) : 161 - 164
  • [2] p21WAF1/Cip1 - PCNA: Fatal attraction
    Galanos, Panagiotis
    Pappas, George
    Gorgoulis, Vassilis G.
    CELL CYCLE, 2016, 15 (23) : 3153 - 3154
  • [3] Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma
    De la Cueva, E.
    Garcia-Cao, I.
    Herranz, M.
    Lopez, P.
    Garcia-Palencia, P.
    Flores, J. M.
    Serrano, M.
    Fernandez-Piqueras, J.
    Martin-Caballero, J.
    ONCOGENE, 2006, 25 (29) : 4128 - 4132
  • [4] Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma
    E De la Cueva
    I García-Cao
    M Herranz
    P López
    P García-Palencia
    J M Flores
    M Serrano
    J Fernández-Piqueras
    J Martín-Caballero
    Oncogene, 2006, 25 : 4128 - 4132
  • [5] Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression
    Kralj, M
    Husnjak, K
    Körbler, T
    Pavelic, J
    CANCER GENE THERAPY, 2003, 10 (06) : 457 - 467
  • [6] Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression
    Marijeta Kralj
    Koraljka Husnjak
    Tajana Körbler
    Jasminka Pavelić
    Cancer Gene Therapy, 2003, 10 : 457 - 467
  • [7] p21WAF1/CIP1 may be a tumor suppressor after all
    Gartel, Andrei L.
    CANCER BIOLOGY & THERAPY, 2007, 6 (08) : 1171 - 1172
  • [8] POST-TRANSCRIPTIONAL REGULATION OF P21WAF1/CIP1 BY P53
    季加孚
    张霁
    焦春雨
    顾晋
    谭立新
    张平
    李培详
    Chinese Journal of Cancer Research, 2001, (02) : 35 - 39
  • [9] The clinical value of p21WAF1/CIP1 expression in superficial bladder cancer
    Chow, NH
    Tzai, TS
    Cheng, HL
    Liu, HS
    Chan, SH
    Tong, YC
    ANTICANCER RESEARCH, 2000, 20 (2B) : 1173 - 1176
  • [10] Interferon Regulatory Factor 1 (IRF-1) induces p21WAF1/CIP1 dependent cell cycle arrest and p21WAF1/CIP1 independent modulation of survivin in cancer cells
    Armstrong, Michaele J.
    Stang, Michael T.
    Liu, Ye
    Gao, Jinbo
    Ren, Baoguo
    Zuckerbraun, Brian S.
    Mahidhara, Raja S.
    Xing, Quanhua
    Pizzoferrato, Eva
    Yim, John H.
    CANCER LETTERS, 2012, 319 (01) : 56 - 65